The Cooperative Health Research in South Tyrol (CHRIS) study: Rationale, objectives, and preliminary results

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Pattaro, Cristian ^a,h   Gögele, Martin ^a   Mascalzoni, Deborah ^a   Melotti, Roberto ^a   Schwienbacher, Christine ^a   Grandi, Alessandro ^a   Foco, Luisa ^a   D'Elia, Yuri ^a   Linder, Barbara ^a   Fuchsberger, Christian ^a   Minelli, Cosetta ^b   Egger, Clemens ^a   Kofink, Lisa S ^a   Zanigni, Stefano ^c   Schäfer, Torsten ^d   Facheris, Maurizio F ^e   Smárason, Sigurur V ^a   Rossini, Alessandra ^a   Hicks, Andrew A ^a   Weiss, Helmuth ^a,f   Pramstaller, Peter P ^a,g,h   more..

^a University of Lubeck   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Dermatological Practice   (Germany)

^e THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^f Hospital of Schlanders Silandro   (Italy)

^g Central Hospital   (Italy)

^h UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PLASMA PROTEIN;

ADULT; AGE; AGED; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC PAIN; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; DIETARY INTAKE; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FAT INTAKE; FEMALE; GENE MAPPING; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEART DISEASE; HUMAN; INHERITANCE; ITALY; LIFESTYLE; LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLOMICS; MOLECULAR GENETICS; NEUROLOGIC DISEASE; NOCICEPTION; PEDIGREE ANALYSIS; PHENOTYPE; PHYSICAL ACTIVITY; PILOT STUDY; POPULATION RESEARCH; QUESTIONNAIRE; SMOKING; SOCIAL ASPECT; TREMOR; UROGENITAL TRACT DISEASE; ADOLESCENT; BIOBANK; ENVIRONMENT; EPIDEMIOLOGY; EXOME; FOLLOW UP; GENETIC PREDISPOSITION; HEALTH STATUS; MEDICAL ETHICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; PEDIGREE; SOFTWARE; URINALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL SPECIMEN BANKS; BLOOD PROTEINS; ENVIRONMENT; ETHICS, MEDICAL; EXOME; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH STATUS; HUMANS; ITALY; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SELECTION; PEDIGREE; PHENOTYPE; PILOT PROJECTS; RESEARCH DESIGN; SOFTWARE; SURVEYS AND QUESTIONNAIRES; URINALYSIS; YOUNG ADULT;

EID: 84959197091     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0704-9     Document Type: Article

References (73)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
2. Harper S. Economic and social implications of aging societies. Science. 2014;346:587-91.
3. Osservatorio Epidemiologico Provinciale. Relazione Sanitaria 2013. Bolzano: Provincia Autonoma di Bolzano-Alto Adige, 2013. p. 63.
4. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933-44.
5. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110:1097-108.
6. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care. 2011;34:216-9.
7. Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, et al. Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care. 2013;36:2286-93.
8. World Health Organization. Neurological disorders: public health challenges. Geneva: World Health Organization; 2006.
9. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112-7.
10. Wenning GK, Kiechl S, Seppi K, Muller J, Hogl B, Saletu M, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol. 2005;4:815-20.
11. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655-79.
12. Pattaro C, Marroni F, Riegler A, Mascalzoni D, Pichler I, Volpato CB, et al. The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives. BMC Med Genet. 2007;8:29.
13. Marroni F, Grazio D, Pattaro C, Devoto M, Pramstaller P. Estimates of genetic and environmental contribution to 43 quantitative traits support sharing of a homogeneous environment in an isolated population from South Tyrol, Italy. Hum Hered. 2008;65:175-82.
14. Hicks AA, Pramstaller PP, Johansson A, Vitart V, Rudan I, Ugocsai P, et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet. 2009;5:e1000672.
15. Kaye J, Curren L, Anderson N, Edwards K, Fullerton SM, Kanellopoulou N, et al. From patients to partners: participant-centric initiatives in biomedical research. Nat Rev Genet. 2012;13:371-6.
16. Mascalzoni D, Dove ES, Rubinstein Y, Dawkins HJ, Kole A, McCormack P, et al. International Charter of principles for sharing bio-specimens and data. Eur J Hum Genet. 2014;23:721-8.
17. Pramstaller PP, Falk M, Schoenhuber R, Poewe W. Validation of a mail questionnaire for parkinsonism in two languages (German and Italian). J Neurol. 1999;246:79-86.
18. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
19. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press; 1983.
20. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
21. Hamilton CM, Strader LC, Pratt JG, Maiese D, Hendershot T, Kwok RK, et al. The PhenX Toolkit: get the most from your measures. Am J Epidemiol. 2011;174:253-60.
22. Fahn S, Tolosa E, Concepcion M. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1993. pp. 271-280.
23. Hess CW, Pullman SL. Tremor: clinical phenomenology and assessment techniques. Tremor Other Hyperkinet Mov (NY) 2012; 2. pii:tre-02-65-365-1.
24. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
25. Edwards RR, Sarlani E, Wesselmann U, Fillingim RB. Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain. 2005;114:315-9.
26. Nielsen CS, Staud R, Price DD. Individual differences in pain sensitivity: measurement, causation, and consequences. J Pain. 2009;10:231-7.
27. Ruscheweyh R, Marziniak M, Stumpenhorst F, Reinholz J, Knecht S. Pain sensitivity can be assessed by self-rating: development and validation of the Pain Sensitivity Questionnaire. Pain. 2009;146:65-74.
28. Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms. 2003;18:80-90.
29. Zanigni S, Calandra-Buonaura G, Grimaldi D, Cortelli P. REM behaviour disorder and neurodegenerative diseases. Sleep Med. 2011;12(Suppl 2):S54-8.
30. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
31. Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012;87:1196-201.
32. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33 (quiz 34-57).
33. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-96.
34. Bernstein D, Fink L. Childhood trauma questionnaire: a retrospective self-report. San Antonio: The Psychological Corporation; 1998.
35. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88:217-33.
36. Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985;4:219-47.
37. Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-65.
38. van Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, van Geijn HP. Heart rate variability. Ann Intern Med. 1993;118:436-47.
39. Zulfiqar U, Jurivich DA, Gao W, Singer DH. Relation of high heart rate variability to healthy longevity. Am J Cardiol. 2010;105:1181-5.
40. Cardoso CR, Moraes RA, Leite NC, Salles GF. Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2014;106:110-7.
41. Stuckey MI, Tulppo MP, Kiviniemi AM, Petrella RJ. Heart rate variability and the metabolic syndrome: a systematic review of the literature. Diabetes Metab Res Rev. 2014;30:784-93.
42. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-31.
43. Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006;367:1674-81.
44. Sinnecker D, Dirschinger RJ, Barthel P, Muller A, Morley-Davies A, Hapfelmeier A, et al. Postextrasystolic blood pressure potentiation predicts poor outcome of cardiac patients. J Am Heart Assoc. 2014;3:e000857.
45. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22:39-52.
46. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord. 2001;16:41-6.
47. Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Doty RL, et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology. 2015;84:182-9.
48. Garland EM, Raj SR, Peltier AC, Robertson D, Biaggioni I. A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology. 2011;76:456-60.
49. Ishizuka K, Tajinda K, Colantuoni C, Morita M, Winicki J, Le C, et al. Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test. Neurosci Res. 2010;66:106-10.
50. Lopez-Lluch G, Santos-Ocana C, Sanchez-Alcazar JA, Fernandez-Ayala DJ, Asencio-Salcedo C, Rodriguez-Aguilera JC, et al. Mitochondrial responsibility in ageing process: innocent, suspect or guilty. Biogerontology. 2015;16:599-620.
51. Biala AK, Dhingra R, Kirshenbaum LA. Mitochondrial dynamics: orchestrating the journey to advanced age. J Mol Cell Cardiol. 2015;83:37-43.
52. Talati M, Hemnes A. Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy. Pulm Circ. 2015;5:269-78.
53. Carvalho C, Correia SC, Cardoso S, Plácido AI, Candeias E, Duarte AI, et al. The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases. Expert Rev Neurother. 2015;15:867-84.
54. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-95.
55. Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, Anto JM, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet. 2005;365:1629-35.
56. Garcia-Larsen V, Luczynska M, Kowalski ML, Voutilainen H, Ahlstrom M, Haahtela T, et al. Use of a common food frequency questionnaire (FFQ) to assess dietary patterns and their relation to allergy and asthma in Europe: pilot study of the GA2LEN FFQ. Eur J Clin Nutr. 2011;65:750-6.
57. Gogele M, Pattaro C, Fuchsberger C, Pramstaller PP. Fertility pattern and family structure in three Alpine settlements in South Tyrol (Italy): marriage cohorts from 1750 to 1949. J Biosoc Sci. 2009;41:697-701.
58. Gogele M, Pattaro C, Fuchsberger C, Minelli C, Pramstaller PP, Wjst M. Heritability analysis of life span in a semi-isolated population followed across four centuries reveals the presence of pleiotropy between life span and reproduction. J Gerontol A Biol Sci Med Sci. 2011;66:26-37.
59. Riegler A, Marroni F, Pattaro C, Gueresi P, Pramstaller PP. Isolation and marriage patterns in four South Tyrolean villages (Italy) during the nineteenth century. J Biosoc Sci. 2008;40:787-91.
60. Panoutsopoulou K, Hatzikotoulas K, Xifara DK, Colonna V, Farmaki AE, Ritchie GR, et al. Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variants. Nat Commun. 2014;5:5345.
61. Charlesworth B. Fundamental concepts in genetics: effective population size and patterns of molecular evolution and variation. Nat Rev Genet. 2009;10:195-205.
62. Doiron D, Burton P, Marcon Y, Gaye A, Wolffenbuttel BH, Perola M, et al. Data harmonization and federated analysis of population-based studies: the BioSHaRE project. Emerg Themes Epidemiol. 2013;10:12.
63. Napolitano M, Santoro F, Puopolo M, Donfancesco C, Galluzzo L, De Grandi A, et al. Development of a pilot project on data sharing among partners of the Italian Hub of Population Biobanks (HIBP): association between lipid profile and socio-demographic variables. Biopreserv Biobank. 2014;12:225-33.
64. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.
65. Gaye A, Marcon Y, Isaeva J, LaFlamme P, Turner A, Jones EM, et al. DataSHIELD: taking the analysis to the data, not the data to the analysis. Int J Epidemiol. 2014;43:1929-44.
66. Demirkan A, van Duijn CM, Ugocsai P, Isaacs A, Pramstaller PP, Liebisch G, et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet. 2012;8:e1002490.
67. Rechel B, Grundy E, Robine JM, Cylus J, Mackenbach JP, Knai C, et al. Ageing in the European Union. Lancet. 2013;381:1312-22.
68. Swede H, Stone CL, Norwood AR. National population-based biobanks for genetic research. Genet Med. 2007;9:141-9.
69. Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M, et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med. 2013;19:1655-60.
70. Aminoff MJ, Greenberg DA, Simon RP. Clinical neurology. 6th ed. Lange: McGraw-Hill Medical; 2005.
71. Wichmann HE, Gieger C, Illig T. MONICA/KORA Study Group. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(Suppl 1):S26-30.
72. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121-32.
73. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord. 2007;22:2386-93.